Patrick O’Gara speaks with Sean Pinney about the evaluation and treatment of patients with severe tricuspid regurgitation.
Pat O'Gara and Laurence Epstein discuss rhythm and device considerations in patients with tricuspid regurgitation.
Juan Granada speaks with Marc Dweck for insights on potential pharmacologic therapies that can impact the progression of aortic stenosis.
Juan Granada and Sammy Elmariah discuss challenges that impact treatment plans for patients with severe aortic stenosis.
Vinod Thourani and Matthew Price review the 2-year outcomes of the TRILUMINATE trial and discuss clinical progression among the control group.
Michael Mack and Carole Warnes discuss the challenges of continued treatment for adults with congenital heart disease and the importance of lifelong care.
Continuing the conversation, Juan Granada hears about Guido Ascione’s recent presentation on the global burden of degenerative mitral valve disease at NY Valves 2025.
Juan Granada speaks with Greg Roth about how the GBD data set is used to assess global trends and determine what health problems need to be addressed by the medical community worldwide.
Michael Mack and Caroline Berchuck discuss how the expectations of healthcare delivery in the United States are shifting due to expanded capabilities of AI and digital technology.
Juan Granada and Pierre Elias continue their conversation on artificial intelligence, including the practical ways it can be implemented in the detection of structural heart disease.
Isaac George discusses the one-year clinical results of the novel polymeric leaflet TRIA valve for patients undergoing surgical mitral valve replacement.
Suzanne Baron and David Elison discuss when to intervene in cases of asymptomatic aortic stenosis based on the complete patient profile.
Brian Lindman, Rahul Sharma, and Sreek Vemulapalli share the benefits of using artificial intelligence tools to assist in identifying patients with aortic stenosis.
Brian Lindman, Sammy Elmariah, and David Wood explain how echocardiogram alerts are assisting in the management and evaluation of aortic stenosis patients.
Bernard Prendergast and Jordan Strom discuss the evolution of AS referral and how earlier treatment impacts patient outcomes.
Philippe Généreux, Brad Oldemeyer, and Jennifer Daniel share their experiences treating asymptomatic aortic stenosis patients in the EARLY TAVR trial.
Michael Mack speaks to Allan Schwartz, a principal investigator of the EARLY TAVR trial, who explains how it informs patient management.
Bernard Prendergast and Philippe Généreux detail the EARLY TAVR trial design and outcomes.
Juan Granada and Pierre Elias discuss how AI is an essential tool for improving screening access and increasing early diagnosis of valvular heart disease.
Juan Granada, MD, and Brian Lindman, MD, share insights on tools and data that can be used to achieve earlier diagnosis and intervention in valvular heart disease.